IP Library Granted Patent US 11,974,934
Granted Patent B2
US 11,974,934 · App. 18/370,819 · Granted May 7, 2024

Intragastric device

Inventors: Mark C. Brister (Encinitas, CA); Paul D. Faucher (Escondido, CA); Neil R. Drake (San Diego, CA); Andrew P. Rasdal (San Diego, CA); Matthew S. Lake (Carlsbad, CA); Dubravka Markovic (San Diego, CA); Amy D. L. VandenBerg (San Diego, CA); Antonio C. Llevares (Chula Vista, CA); Josefina Nider (San Diego, CA)
Assignee: ReShape Lifesciences Inc.
A61F5/003A61F5/0036A61F5/0089A61M25/10181A61M29/02A61M25/10185
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,974,934
App. No.
18/370,819
Granted
May 7, 2024
Kind
B2
Abstract

Devices and methods for treating obesity are provided. More particularly, intragastric devices and methods of fabricating, deploying, inflating, monitoring, and retrieving the same are provided.

Claims (26)

1. An intragastric balloon system, comprising:

a capsule configured to be swallowable by a patient by normal peristalsis and to degrade in a gastric environment;

a balloon compacted and contained within the capsule, the balloon including an outer surface, an inner surface, an interior cavity, a fill valve, and a release valve, wherein the fill valve and the release valve are separate valves;

wherein the fill valve is a self-sealing valve that is configured to self-seal after a catheter is detached from the fill valve;

wherein at least a degradable portion of the release valve is configured to degrade in an internal environment of the interior cavity of the balloon when a liquid is in the interior cavity of the balloon and in response to the liquid being in contact with the degradable portion of the release valve;

wherein when the liquid is in the interior cavity of the balloon, the degradable portion of the release valve is configured to be degraded by contact with the liquid such that the degradation process opens the release valve to allow the liquid to travel from the interior cavity of the balloon into the gastric environment thereby deflating the balloon; and

wherein the release valve comprises a seam where at least two portions of the balloon are joined together.

2. The intragastric balloon system of claim 1 , wherein the degradable portion of the release valve is configured to degrade in the internal environment of the interior cavity of the balloon and thereby open the release valve at approximately between 1 month and 6 months after inflating the balloon with the liquid.

3. The intragastric balloon system of claim 1 , wherein the degradable portion of the release valve is configured to degrade in the internal environment of the interior cavity of the balloon and thereby open the release valve at approximately 3 months after inflating the balloon with the liquid.

4. The intragastric balloon system of claim 1 , wherein the deflated balloon is configured to pass through a remainder of the patient's digestive tract.

5. The intragastric balloon system of claim 1 , wherein at approximately between 1 month and 6 months after inflating the balloon with the liquid, the degradable portion of the release valve is configured to degrade and allow the liquid to drain from the interior cavity of the balloon.

6. The intragastric balloon system of claim 1 , wherein the balloon is configured to transit a gastrointestinal tract and be excreted after the balloon is deflated.

7. The intragastric balloon system of claim 1 , wherein the interior cavity is defined by the inner surface of the balloon.

8. The intragastric balloon system of claim 1 , wherein the outer surface of the balloon separates the gastric environment from the release valve.

9. The intragastric balloon system of claim 1 , wherein the compacted balloon is configured to contain no liquid before the patient swallows the capsule.

10. The intragastric balloon system of claim 1 , wherein the liquid comprises saline.

11. The intragastric balloon system of claim 1 , wherein a portion of the seam is configured to degrade based on the internal environment of the balloon instead of an external environment outside the balloon.

12. The intragastric balloon system of claim 1 wherein a portion of the seam is configured to degrade based on a pH or a humidity condition in the internal environment of the balloon.

13. The intragastric balloon system of claim 1 , wherein a portion of the seam is configured to degrade based on the liquid in the internal environment of the balloon.

14. The intragastric balloon system of claim 13 , wherein the liquid comprises water.

15. The intragastric balloon system of claim 14 , wherein the water comprises saline.

16. The intragastric balloon system of claim 1 , wherein the seam comprises an erodible material.

17. The intragastric balloon system of claim 1 , wherein the seam comprises a single layer.

18. The intragastric balloon system of claim 1 , wherein the seam comprises multiple layers.

19. The intragastric balloon system of claim 1 , wherein a portion of the seam is configured to degrade, and upon degradation of the degradable portion of the seam, the at least two portions of the balloon are separated to break open the balloon.

20. The intragastric balloon system of claim 19 , wherein the degradable portion of the seam is configured to degrade based on the internal environment of the balloon instead of an external environment outside the balloon.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 23, 2025
From: RESHAPE LIFESCIENCES INC.
To: MEDTIMO INC.
Reel/Frame 072955/0766 →
Continuity (8)
Continuation 17581792 · Jan 21, 2022
Continuation 16792094 · Feb 14, 2020
Continuation 15906942 · Feb 27, 2018
Continuation 15690095 · Aug 29, 2017
Continuation 14860538 · Sep 21, 2015
Continuation 14227195 · Mar 27, 2014
Continuation 13510921
Related Publication 20240016635A1 · Jan 18, 2024